300705SZSE

Pre-disclosure Announcement on Shareholder Share Reduction

✨ AI Summary

This announcement informs that Yang Yang, a director and general manager, plans to reduce his shareholding by up to 153,021 shares within three months after the announcement date. This represents 0.031% of the company's total share capital. The reduction is due to personal funding needs and will be conducted through centralized bidding. The company confirms that this plan aligns with previously disclosed commitments.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Yang Yang, a shareholder holding 612,087 shares (0.124% of the total share capital), guarantees that the information provided to the company is true, accurate, and complete, without false records, misleading statements, or significant omissions. The company and all members of the board of directors ensure that the announcement content is consistent with the information provided by the information disclosure obligor.

Special Reminder: Mr. Yang Yang, who holds 612,087 shares (0.124% of the total share capital), plans to reduce his shareholding by no more than 153,021 shares (0.031% of the total share capital) through centralized bidding within three months after the announcement date, starting from 15 trading days after this announcement.

Hunan Jiudian Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") has recently received a "Share Reduction Plan Notification Letter" from Mr. Yang Yang. The relevant details are announced as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.